Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.

Source:http://linkedlifedata.com/resource/pubmed/id/19452240

Download in:

View as

General Info

PMID
19452240